Epigallocatechin Gallate (EGCG) to Improve Cognitive Performance in Foetal Alcohol Syndrome (FAS) Children

Key facts

Sponsor

Fundacion Clinic per a la Recerca Biomédica

Principal Investigator

Oscar Garcia-Algar, PhD

Parc de Salut Mar

Intervention

Epigallocatechin gallate(dietary_supplement)

Enrollment

36 enrolled

Eligibility

5-16 years · All sexes

Timeline

2016 – 2017

Study locations (1)

• Parc de Salut Mar, Barcelona, Barcelona, Spain

Collaborators

Parc de Salut Mar

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Fetal alcohol syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07016009
  Thrive Person-Centered Planning Program for Young Adults With Fetal Alcohol Spectrum Disorders
  University of Rochester
• RECRUITINGNANCT05686473
  Psychoeducation of Parents to Children With FASD
  Sorlandet Hospital HF
• RECRUITINGNANCT06847165
  Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure
  University of California, Los Angeles
• ENROLLING BY INVITATIONNANCT06935461
  Families Moving Forward Bridges: An Early Intervention for Infants and Toddlers With PAE With or At-risk for FASD
  University of Washington
• RECRUITINGNANCT06638463
  My Health Coach App RCT
  University of Rochester
• RECRUITINGNANCT05960461
  Families Moving Forward (FMF) Connect Pro for Mental Health Providers
  University of Rochester
• RECRUITINGNANCT06005181
  The Synchrony Study: Examining Music Training for Children With FASD
  The Mind Research Network
• RECRUITINGPHASE2NCT04395196
  RCT of Prenatal Choline Supplementation During Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol Exposure
  Wayne State University

See all trials for Fetal alcohol syndrome →